Drug Price Transparency

Name: Drug Price Transparency
Creator: Newspaper Daily
License: United States government work; public domain unless the source record says otherwise.

Drug Price Transparency organizes records from CMS data API into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.

Records: 5,000
Last changed: 08/30/2026
Update schedule: 50 16 1 */3 * UTC
Coverage: 01/01/2024–01/01/2024
Method: Methodology

Record	Record Date	Vuga Group	Change Status	Recency Days	Public Significance Score
Enbrel Mini	01/01/2024	Etanercept	increased	972.23	100
Enbrel Sureclick	01/01/2024	Etanercept	increased	972.23	100
Enbrel Sureclick	01/01/2024	Etanercept	increased	972.23	100
Enbrel	01/01/2024	Etanercept	increased	972.23	100
Enbrel	01/01/2024	Etanercept	increased	972.23	100
Enhertu	01/01/2024	Fam-Trastuzumab Deruxtecn-Nxki	increased	972.23	100
Enhertu	01/01/2024	Fam-Trastuzumab Deruxtecn-Nxki	increased	972.23	100
Enspryng	01/01/2024	Satralizumab-Mwge	increased	972.23	100
Enspryng	01/01/2024	Satralizumab-Mwge	increased	972.23	100
Entyvio Pen	01/01/2024	Vedolizumab	increased	972.23	100
Entyvio Pen	01/01/2024	Vedolizumab	increased	972.23	100
Entyvio	01/01/2024	Vedolizumab	increased	972.23	100
Entyvio	01/01/2024	Vedolizumab	increased	972.23	100
Epclusa	01/01/2024	Sofosbuvir/Velpatasvir	increased	972.23	100
Epclusa	01/01/2024	Sofosbuvir/Velpatasvir	increased	972.23	100
Epinephrine	01/01/2024	Epinephrine	increased	972.23	100
Epipen 2-Pak	01/01/2024	Epinephrine	increased	972.23	100
Epipen 2-Pak	01/01/2024	Epinephrine	increased	972.23	100
Epkinly	01/01/2024	Epcoritamab-Bysp	increased	972.23	100
Epkinly	01/01/2024	Epcoritamab-Bysp	increased	972.23	100
Epogen	01/01/2024	Epoetin Alfa	increased	972.23	100
Epogen	01/01/2024	Epoetin Alfa	increased	972.23	100
Erivedge	01/01/2024	Vismodegib	increased	972.23	100
Erivedge	01/01/2024	Vismodegib	increased	972.23	100
Erleada	01/01/2024	Apalutamide	increased	972.23	100
Erleada	01/01/2024	Apalutamide	increased	972.23	100
Estring	01/01/2024	Estradiol	increased	972.23	100
Estring	01/01/2024	Estradiol	increased	972.23	100
Ethacrynate Sodium	01/01/2024	Ethacrynate Sodium	increased	972.23	100
Ethacrynate Sodium	01/01/2024	Ethacrynate Sodium	increased	972.23	100
Etopophos	01/01/2024	Etoposide Phosphate	increased	972.23	100
Etopophos	01/01/2024	Etoposide Phosphate	increased	972.23	100
Evenity (2 Syringes)	01/01/2024	Romosozumab-Aqqg	increased	972.23	100
Evenity (2 Syringes)	01/01/2024	Romosozumab-Aqqg	increased	972.23	100
Evenity	01/01/2024	Romosozumab-Aqqg	increased	972.23	100
Evenity	01/01/2024	Romosozumab-Aqqg	increased	972.23	100
Everolimus	01/01/2024	Everolimus	increased	972.23	100
Everolimus	01/01/2024	Everolimus	increased	972.23	100
Everolimus	01/01/2024	Everolimus	increased	972.23	100
Everolimus	01/01/2024	Everolimus	increased	972.23	100
Everolimus	01/01/2024	Everolimus	increased	972.23	100
Everolimus	01/01/2024	Everolimus	increased	972.23	100
Evkeeza	01/01/2024	Evinacumab-Dgnb	increased	972.23	100
Evkeeza	01/01/2024	Evinacumab-Dgnb	increased	972.23	100
Evrysdi	01/01/2024	Risdiplam	increased	972.23	100
Evrysdi	01/01/2024	Risdiplam	increased	972.23	100
Exjade	01/01/2024	Deferasirox	increased	972.23	100
Exjade	01/01/2024	Deferasirox	increased	972.23	100
Exkivity	01/01/2024	Mobocertinib Succinate	increased	972.23	100
Exkivity	01/01/2024	Mobocertinib Succinate	increased	972.23	100